Furthermore, treatment with C188–9, a specific STAT3 inhibitor, strongly suppressed GNAS overexpression-induced IL-6 mRNA expression in HCC cells (Fig. 3d). The gene discussed is STAT3; the disease is hepatocellular carcinoma.